Increased gallstone risk in humans conferred by common variant of hepatic ATP-binding cassette transporter for cholesterol

Hepatology

Volumn 46, Issue 3, 2007, Pages 793-801

  Grünhage, Frank ^a   Acalovschi, Monica ^b   Tirziu, Simona ^b   Walier, Maja ^c   Wienker, Thomas F ^c   Ciocan, Anca ^b   Mosteanu, Ofelia ^b   Sauerbruch, Tilman ^a   Lammert, Frank ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER G5; ABC TRANSPORTER G8; CHOLESTEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CHOLECYSTECTOMY; CONTROLLED STUDY; FEMALE; GALLSTONE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; ATP-BINDING CASSETTE TRANSPORTERS; CHOLESTEROL; CHROMOSOMES, HUMAN, PAIR 2; FEMALE; GALLSTONES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE (GENETICS); LIPOPROTEINS; LIVER; MALE; MIDDLE AGED; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 34548765965     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21847     Document Type: Article

References (50)

1. Acalovschi M, Pascu M, Iobagiu S, Petrescu M, Olinici CD, Ban A, et al. Increasing gallstone prevalence and cholecystectomy rate in a large Romanian town. A necropsy study. Dig Dis Sci 1995;40:2582-2586.
2. Lammert F, Sauerbruch T. Mechanisms of disease: the genetic epidemiology of gallbladder stones. Nat Clin Pract Gastroenterol Hepatol 2005;2:423-433.
3. Everhart JE, Yeh F, Lee ET, Hill MC, Fabsitz R, Howard BV, et al. Prevalence of gallbladder disease in American Indian populations: findings from the Strong Heart Study. Hepatology 2002;35:1507-1512.
4. Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease. Lancet 2006;368:230-239.
5. Liver Diseases Subcommittee of the Digestive Diseases Interagency Coordinating Committee. Gallbladder and biliary disease. In: National Institutes of Health, ed. Action Plan for Liver Disease Research. Bethesda, MD: National Institutes of Health; 2004:144-150.
6. Lazaridis KN. Genetics and genomics of complex diseases in hepatology. Semin Liver Dis 2007;27:1-2.
7. Carey MC, Paigen B. Epidemiology of the American Indians' burden and its likely genetic origins. HEPATOLOGY 2002;36:781-791.
8. Wittenburg H, Lammert F. Genetic predisposition to gallbladder stones. Semin Liver Dis 2007;27:109-121.
9. Miquel JF, Covarrubias C, Villaroel L, Mingrone G, Greco AV, Puglielli L, et al. Genetic epidemiology of cholesterol cholelithiasis among Chilean Hispanics, Amerindians, and Maoris. Gastroenterology 1998;115:937-946.
10. Katsika D, Grjibovski A, Einarsson C, Lammert F, Lichtenstein P, Marschall HU. Genetic and environmental influences on symptomatic gallstone disease: a Swedish study of 43,141 twin pairs. HEPATOLOGY 2005;41:1138-1143.
11. Nakeeb A, Comuzzie AG, Martin L, Sonnenberg GE, Swartz-Basile D, Kissebah AH, et al. Gallstones: genetics versus environment. Ann Surg 2002;235:842-849.
12. Rosmorduc O, Hermelin B, Boelle PY, Parc R, Taboury J, Poupon R. ABCB4 gene mutation-associated cholelithiasis in adults. Gastroenterology 2003;125:452-459.
13. Van Mil SW, van der Woerd WL, van der Brugge G, Sturm E, Jansen PL, Bull LN, van den Berg IE, et al. Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11. Gastroenterology 2004;127:379-384.
14. Lammert F, Carey MC, Paigen B. Chromosomal organization of candidate genes involved in cholesterol gallstone formation: a murine gallstone map. Gastroenterology 2001;120:221-238.
15. Lyons MA, Wittenburg H. Cholesterol gallstone susceptibility loci: a mouse map, candidate gene evaluation, and guide to human LITH genes. Gastroenterology 2006;131:1943-1970.
16. Wittenburg H, Lyons MA, Li R, Churchill GA, Carey MC, Paigen B. FXR and ABCG5/ABCG8 as determinants of cholesterol gallstone formation from quantitative trait locus mapping in mice. Gastroenterology 2003;125:868-881.
17. Berge KE, Tian H, Graf GA, Yu L, Grishin NV, Schultz J, et al. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 2000;290:1771-1775.
18. Carey MC, Lamont JT. Cholesterol gallstone formation. 1. Physical-chemistry of bile and biliary lipid secretion. Prog Liver Dis 1992;10:139-163.
19. Kern F. Effects of dietary cholesterol on cholesterol and bile acid homeostasis in patients with cholesterol gallstones. J Clin Invest 1994;93:1186-1194.
20. Wang DQ. Regulation of intestinal cholesterol absorption. Annu Rev Physiol 2007;69:221-248.
21. Lee MH, Lu K, Hazard S, Yu H, Shulenin S, Hidaka H, et al. Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat Genet 2001;27:79-83.
22. Berge KE, von Bergmann K, Lütjohann D, Guerra R, Grundy SM, Hobbs HH, et al. Heritability of plasma noncholesterol sterols and relationship to DNA sequence polymorphism in ABCG5 and ABCG8. J Lipid Res 2002;43:486-494.
23. Gylling H, Hallikainen M, Pihlajamaki J, Agren J, Laakso M, Rajaratnam RA, et al. Polymorphisms in the ABCG5 and ABCG8 genes associate with cholesterol absorption and insulin sensitivity. J Lipid Res 2004;45:1660-1665.
24. Plat J, Bragt MC, Mensink RP. Common sequence variations in ABCG8 are related to plant sterol metabolism in healthy volunteers. J Lipid Res 2005;46:68-75.
25. Acalovschi M, Ciocan A, Mosteanu O, Tirziu S, Chiorean E, Keppeler H, et al. Are plasma lipid levels related to ABCG5/ABCG8 polymorphisms? A preliminary study in siblings with gallstones. Eur J Intern Med 2006;17:490-494.
26. Hauser ER, Haines J, Goldgar DE. Nonparametric linkage analysis. In: Haines JL, Pericak-Vanes M, eds. Genetic Analysis of Complex Diseases. 2nd ed. Hoboken, NJ: John Wiley & Sons; 2006:283-328.
27. Grimes DA, Schulz KF. Compared to what? Finding controls for case-control studies. Lancet 2005;365:1429-1433.
28. Kajinami K, Brousseau ME, Nartsupha C, Ordovas JM, Schaefer EJ. ATP binding cassette transporter G5 and G8 genotypes and plasma lipoprotein levels before and after treatment with atorvastatin. J Lipid Res 2004;45:653-656.
29. Hubacek JA, Berge KE, Srefkova J, Pitha J, Skodova Z, Lanska V, et al. Polymorphisms in ABCG5 and ABCG8 transporters and plasma cholesterol levels. Physiol Res 2004;53:395-401.
30. Hill WG, Weir BS. Maximum-likelihood estimation of gene location by linkage disequilibrium. Am J Hum Genet 1994;54:705-714.
31. Abecasis GR, Cookson WO. GOLD - graphical overview of linkage disequilibrium. Bioinformatics 2000;16:182-183.
32. Dietter J, Mattheisen M, Furst R, Ruschendorf F, Wienker TF, Strauch K. Linkage analysis using sex-specific recombination fractions with GENE-HUNTER-MODSCORE. Bioinformatics 2007;23:64-70.
33. Lu K, Lee MH, Hazard S, Brooks-Wilson A, Hidaka H, Kojima H, et al. Two genes that map to the STSL locus cause sitosterolemia: genomic strucrure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively. Am J Hum Genet 2001;69:278-290.
34. Hubacek JA, Berge KE, Cohen JC, Hobbs HH. Mutations in ATP-cassette binding proteins G5 (ABCG5) and G8 (ABCG8) causing sitosterolemia. Hum Mutat 2001;18:359-360.
35. Lammert F, Wasmuth HE, Méndez-Sánchez N, Rahbar-Tabrizi N, Schirin-Sokhan R, King-Martínez AC, et al. Common haplotypes of the ABCG5/G8 genes encoding the hepatocanalicular cholesterol transporter are associated with cholecystolithiasis. Eur J Clin Invest 2004;34:28-29.
36. Kong A, Cox NJ. Allele-sharing models: LOD scores and accurate linkage tests. Am J Hum Genet 1997;61:1179-1188.
37. Lindner TH, Hoffmann K. easyLINKAGE: a PERL script for easy and automated two-/multi-point linkage analyses. Bioinformatics 2005;21:405-407.
38. Cordell HJ. Bias toward the null hypothesis in model-free linkage analysis is highly dependent on the test statistic used. Am J Hum Genet 2004;74:1294-1302.
39. Abecasis GR, Wigginton JE. Handling marker-marker linkage disequilibrium: pedigree analysis with clustered markers. Am J Hum Genet 2005;77:754-767.
40. Puppala S, Dodd GD, Fowler S, Arya R, Schneider J, Farook VS, et al. A genomewide search finds major susceptibility loci for gallbladder disease on chromosome 1 in Mexican Americans. Am J Hum Genet 2006;78:377-392.
41. Schafmayer C, Tepel J, Franke A, Buch S, Lieb S, Seeger M, et al. Investigation of the Lith1 candidate genes ABCB11 and LXRA in human gallstone disease. HEPATOLOGY 2006;44:650-657.
42. Lammert F, Wang DQ, Hillebrandt S, Geier A, Fickert P, Trauner M, et al. Spontaneous cholecysto- and hepatolithiasis in Mdr2-/- mice: a model for low phospholipid-associated cholelithiasis. HEPATOLOGY 2004;39:117-128.
43. Buch S, Schafmayer C, Völzke H, Becker C, Franke A, von Eller-Eberstein H, et al. A genome-wide association scan identifies the hepatic cholesterol transporter ABCG5/ABCG8 as a susceptibility factor for human gallstone disease. Nat Genet 2007. In press.
44. Wang J, Sun F, Zhang DW, Ma Y, Xu F, Belani JD, et al. Sterol transfer by ABCG5 and ABCG8: in vitro assay and reconstitution. J Biol Chem 2006;281:27894-27904.
45. Gustafsson U, Sahlin S, Einarsson C. Biliary lipid composition in patients with cholesterol and pigment gallstones and gallstone-free subjects: deoxycholic acid does not contribute to formation of cholesterol gallstones. Eur J Clin Invest 2000;30:1099-1106.
46. Shaffer EA, Small DM. Biliary lipid secretion in cholesterol gallstone disease. The effect of cholecystectomy and obesity. J Clin Invest 1977;59:828-840.
47. Angelin B, Backman L, Einarsson K, Eriksson L, Ewerth S. Hepatic cholesterol metabolism in obesity: activity of microsomal 3-hydroxy-3- methylglutaryl coenzyme A reductase. J Lipid Res 1982;23:770-773.
48. Smit JW, van Erpecum KJ, Stolk MF, Geerdink RA, Cluysenaer OJ, Erkelens DW, et al. Successful dissolution of cholesterol gallstone during treatment with pravastatin. Gastroenterology 1992;103:1068-1070.
49. Smit JW, van Erpecum KJ, Renooij W, Stolk MF, Edgar P, Doornewaard H, et al. The effects of the 3-hydroxy, 3-methylglutatyl coenzyme A reductase inhibitor pravastatin on bile composition and nucleation of cholesterol crystals in cholesterol gallstone disease. HEPATOLOGY 1995;21:1523-1529.
50. Lammert F, Wasmuth HE, Matern S. Molecular genetics of gallstone formation: human association studies and comparative genomics. In: Adler G, Blum HE, Fuchs M, Stange EF, eds. Gallstones: Pathogenesis and Treatment. Dordrecht: Kluwer Academic Publishers; 2004:28-39.